SCHEMBL4668512

SCHEMBL4668512

CCc1ccc(Nc2c(-c3ccc(OC)nc3)c(C3CC3)nn2-c2ncccc2C)c(C(=O)O)c1

nearest known ligand 0.41

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
ADORA1 P30542 18/20 0.41
ADORA3 P0DMS8 1/20 0.41
ADORA2A P29274 1/20 0.39
ADORA2B P29275 1/20 0.39
DHODH Q02127 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14600994 0.91 ADORA1 (0.46) ADORA1ADORA3ADORA2AADORA2BDHODH
SCHEMBL14600455 0.90 DHODH (0.47) ADORA1ADORA3ADORA2AADORA2BDHODH
SCHEMBL4667038 0.90 ADORA1 (0.39) ADORA1ADORA3DHODH
SCHEMBL4667499 0.87 DHODH (0.41) ADORA1ADORA3ADORA2AADORA2BDHODH
SCHEMBL14600254 0.84 ADORA1 (0.51) ADORA1ADORA3ADORA2AADORA2BDHODH
SCHEMBL14600256 0.83 DHODH (0.44) ADORA1ADORA3ADORA2AADORA2BDHODH
SCHEMBL4668599 0.82 ADORA1 (0.50) ADORA1ADORA3ADORA2AADORA2BDHODH
SCHEMBL14600995 0.80 ADORA1 (0.46) ADORA1ADORA3DHODH
SCHEMBL14600459 0.80 DHODH (0.49) ADORA1DHODH
SCHEMBL14600704 0.79 ADORA1 (0.46) ADORA1ADORA3ADORA2AADORA2BDHODH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1928455-A1 ANILINOPYRAZOLE DERIVATIVES USEFUL FOR THE TREATMENT OF DIABETES Bayer Healthcare, LLC (US) 2008-06-11 EP disclosed
WO-2007027842-A1 ANILINOPYRAZOLE DERIVATIVES USEFUL FOR THE TREATMENT OF DIABETES BAYER HEALTHCARE LLC (US) 2007-03-08 WO disclosed
WO-2007027842-A1 ANILINOPYRAZOLE DERIVATIVES USEFUL FOR THE TREATMENT OF DIABETES BAYER HEALTHCARE LLC (US) 2007-03-08 WO disclosed